Dimitry M. Danilenko

Medicine · Health Sciences

46h-index12.3kcitations105works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(23), Cell Adhesion Molecules Research(15), T-cell and B-cell Immunology(13), Immunotherapy and Immune Responses(11), Psoriasis: Treatment and Pathogenesis(10)

Publications105 total

Supplementary Figure 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Data from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Supplementary Figure 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Data from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
2023Open Access
Assessment of Skin Toxicity in an in Vitro Reconstituted Human Epidermis Model Using Deep Learning
American Journal Of Pathology·2022· 12 citedOpen Access
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer
Frontiers in Immunology·2019· 194 citedOpen Access
Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin
British Journal of Pharmacology·2019· 34 citedOpen Access
Single cell-produced and <i>in vitro</i>-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar <i>in vitro</i> and <i>in vivo</i> properties
mAbs·2018· 16 citedOpen Access
Nonclinical safety assessment of a human interleukin‐22<scp>FC IG</scp> fusion protein demonstrates in vitro to in vivo and cross‐species translatability
Pharmacology Research & Perspectives·2018· 14 citedOpen Access
Randomized Phase I Healthy Volunteer Study of <scp>UTTR</scp>1147A (<scp>IL</scp>‐22Fc): A Potential Therapy for Epithelial Injury
Clinical Pharmacology & Therapeutics·2018· 64 cited
Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases
Biochemical Pharmacology·2018· 55 cited
Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease
Alimentary Pharmacology & Therapeutics·2018· 36 citedOpen Access
The Integumentary System
Elsevier eBooks·2017· 5 cited
List of Contributors
Elsevier eBooks·2017
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing
Cancer Cell·2017· 289 citedOpen Access
P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial
Journal of Crohn s and Colitis·2017· 4 citedOpen Access
IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice
PLoS ONE·2017· 94 citedOpen Access
Membrane proximal epitope facilitates efficient T cell synapse formation by CD3-bispecific antibodies and is a requirement for myeloma cell killing by anti-FcRH5/CD3
2017
page 1 of 6Next →

Frequent Co-authors

Wenjun Ouyang(7), Brian D. Ring(7), Glenn F. Pierce(6), M Rose(5), Nico Ghilardi(4), Sheila Scully(4), W. Scott Simonet(4), Flavius Martin(4), Wyne P. Lee(4), Paul V. Rossitto(4), Patricia Valdez(3), Frédéric J. de Sauvage(3), J E Tarpley(3), David L. Lacey(3), Patrick Caplazi(3), Mary Keir(3), Mercedesz Balázs(3), Hung Q. Nguyen(3), Eugene S. Medlock(3), Arlen Thomason(3)